Table 2.
Risk factor distribution for IC
| Variable | Number of patients (percentage) |
|---|---|
| Immunosuppressive therapy | • 14 (12.3%) |
| Solid-organ transplant | • Renal transplant: 6 (5.3%) |
| • Heart transplant: 2 (1.8%) | |
| • Liver transplant: 1 (0.9%) | |
| • Heart and lung transplant: 1 (0.9%) | |
| • No transplant: 104 (91.2%) | |
| Acute kidney injury (AKI) | • No AKI: 39 (34.2%) |
| • AKI present: 75 (65.8%) | |
| • AKI patients requiring dialysis: 14 patients | |
| SOFA score | • <7: 37 (32.4) |
| • ≥7: 52 (45.6%) | |
| • Not available: 25 (21.9) | |
| Central venous catheter | • No line: 38 (33.3%) |
| • Line present: 76 (66.7%) | |
| • C line removed after CLABSI/IC suspicion: 48 (42.1%) | |
| Foley catheter | 73 (64%) |
| Total parenteral nutrition (TPN) | • NO TPN: 104 (91.2%) |
| • TPN: 8 (7%) | |
| • Feeding jejunostomy (FJ) FEEDS: 1 (0.9%) | |
| • Percutaneous endoscopic gastrostomy (PEG): 1 (0.9%) | |
| Surgery | • No surgery: 69 (60.5) |
| • Non-GI surgery: 28 (24.6%) | |
| • GI surgery: 17 (14.9) | |
| Prior antibiotics usage (intravenous antibiotic used for at least 3 days within the previous 1 week) | • 114 (100%) |
| Bacteremia | • Concomitant bacteremia: 5 (4.4%) |
| • Previous bacteremia: 25 (21.9%) | |
| • No bacteremia: 84 (73.7%) | |
| Prior antifungal exposure for at least >3 days (in last 14 days) | • No exposure: 91 (79.8%) |
| • Fluconazole: 21 (18.4%) | |
| • Amphotericin B: 1 (0.9%) | |
| • Echinocandin: 1 (0.9%) |